177 related articles for article (PubMed ID: 36716280)
1. Identifying Biomarkers Using Support Vector Machine to Understand the Racial Disparity in Triple-Negative Breast Cancer.
Sahoo B; Pinnix Z; Sims S; Zelikovsky A
J Comput Biol; 2023 Apr; 30(4):502-517. PubMed ID: 36716280
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
Front Public Health; 2020; 8():576964. PubMed ID: 33415093
[TBL] [Abstract][Full Text] [Related]
3. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
4. The persisting puzzle of racial disparity in triple negative breast cancer: looking through a new lens.
Garlapati C; Joshi S; Sahoo B; Kapoor S; Aneja R
Front Biosci (Schol Ed); 2019 Mar; 11(1):75-88. PubMed ID: 30844737
[TBL] [Abstract][Full Text] [Related]
5. Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants.
Siddharth S; Sharma D
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558195
[TBL] [Abstract][Full Text] [Related]
6. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
7. Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.
Siddharth S; Parida S; Muniraj N; Hercules S; Lim D; Nagalingam A; Wang C; Gyorffy B; Daniel JM; Sharma D
Elife; 2021 Dec; 10():. PubMed ID: 34889737
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.
MacCuaig WM; Thomas A; Claros-Sorto JC; Gomez-Gutierrez JG; Alexander AC; Wellberg EA; Grizzle WE; McNally LR
Biotech Histochem; 2022 Jan; 97(1):1-10. PubMed ID: 34979848
[TBL] [Abstract][Full Text] [Related]
11. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
Sung H; Wiese D; Jatoi I; Jemal A
JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
[TBL] [Abstract][Full Text] [Related]
12. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
13. Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.
Newman LA; Kaljee LM
JAMA Surg; 2017 May; 152(5):485-493. PubMed ID: 28355428
[TBL] [Abstract][Full Text] [Related]
14. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
[TBL] [Abstract][Full Text] [Related]
15. Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention.
Jinna N; Jovanovic-Talisman T; LaBarge M; Natarajan R; Kittles R; Sistrunk C; Rida P; Seewaldt VL
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139643
[TBL] [Abstract][Full Text] [Related]
16. Genomic analysis of racial differences in triple negative breast cancer.
Chang CS; Kitamura E; Johnson J; Bollag R; Hawthorn L
Genomics; 2019 Dec; 111(6):1529-1542. PubMed ID: 30366040
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females.
Ensenyat-Mendez M; Solivellas-Pieras M; Llinàs-Arias P; Íñiguez-Muñoz S; Baker JL; Marzese DM; DiNome ML
JAMA Netw Open; 2023 Oct; 6(10):e2335821. PubMed ID: 37796506
[TBL] [Abstract][Full Text] [Related]
18. LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.
Torres-Luquis O; Madden K; N'dri NM; Berg R; Olopade OF; Ngwa W; Abuidris D; Mittal S; Lyn-Cook B; Mohammed SI
Breast Cancer (Dove Med Press); 2019; 11():1-12. PubMed ID: 30588086
[TBL] [Abstract][Full Text] [Related]
19. High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
Yang X; Amgad M; Cooper LAD; Du Y; Fu H; Ivanov AA
J Transl Med; 2020 Sep; 18(1):334. PubMed ID: 32873298
[TBL] [Abstract][Full Text] [Related]
20. Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.
Lehrberg A; Davis MB; Baidoun F; Petersen L; Susick L; Jenkins B; Chen Y; Ivanics T; Rakitin I; Bensenhaver J; Proctor E; Nathanson SD; Newman LA
Breast J; 2021 Jul; 27(7):573-580. PubMed ID: 33738890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
